早产儿支气管肺发育不良相关预测模型研究

李静兰, 孙文强, 朱雪萍

中国儿童保健杂志 ›› 2023, Vol. 31 ›› Issue (4) : 395-398.

PDF(550 KB)
PDF(550 KB)
中国儿童保健杂志 ›› 2023, Vol. 31 ›› Issue (4) : 395-398. DOI: 10.11852/zgetbjzz2022-0522
综述

早产儿支气管肺发育不良相关预测模型研究

  • 李静兰, 孙文强, 朱雪萍
作者信息 +

Research progress in the prediction model of bronchopulmonary dysplasia in preterm infants

  • LI Jinglan, SUN Wenqiang, ZHU Xueping
Author information +
文章历史 +

摘要

支气管肺发育不良(BPD)是一种好发于早产儿的、以肺泡简单化及肺血管发育迟缓为主要特征,同时伴有肺纤维化、囊性变及肺不张的慢性肺疾病,至今尚无有效治疗办法,一经发生不可逆转,严重影响患儿的生存率和近远期预后。因此,早发现、早预防、早治疗对评估及改善患儿预后极其重要。目前,国内外针对BPD发生的高危因素进行了大量研究,并建立了多种BPD发生的早期预测模型。本文将有关早产儿BPD预测模型的最新研究进展作一综述,旨在为临床早期干预、预防BPD的发生和发展提供理论依据。

Abstract

Bronchopulmonary dysplasia (BPD) is a chronic lung disease characterized by simple pulmonary alveoli and pulmonary vascular retardation, accompanied by pulmonary fibrosis, cystic degeneration and atelectasis. There is no effective treatment for BPD, and once it occurs, it is irreversible and seriously affects the survival rate and prognosis of children in the near and long term. Therefore, early detection, prevention, and treatment are important to assess and improve the prognosis of children. At present, research has been done on the high risk factors of BPD at home and abroad, and a variety of early warning models of BPD have been established. This article reviews the latest research progress of BPD early warning model in preterm infants, in order to provide theoretical basis for early clinical intervention and prevention of the occurrence and development of BPD.

关键词

早产儿 / 支气管肺发育不良 / 预测模型

Key words

preterm infants / bronchopulmonary dysplasia / predictive models

引用本文

导出引用
李静兰, 孙文强, 朱雪萍. 早产儿支气管肺发育不良相关预测模型研究[J]. 中国儿童保健杂志. 2023, 31(4): 395-398 https://doi.org/10.11852/zgetbjzz2022-0522
LI Jinglan, SUN Wenqiang, ZHU Xueping. Research progress in the prediction model of bronchopulmonary dysplasia in preterm infants[J]. Chinese Journal of Child Health Care. 2023, 31(4): 395-398 https://doi.org/10.11852/zgetbjzz2022-0522
中图分类号: R722.6   

参考文献

[1] Abman SH, Bancalari E, Jobe A. The evolution of bronchopulmonary dysplasia after 50 years[J]. Am J Respir Crit Care Med,2017,195(4):421-424.
[2] Thébaud B, Goss KN, Laughon M, et al. Bronchopulmonary dysplasia[J]. Nat Rev Dis Primers,2019,5(1):78.
[3] Schittny JC. Development of the lung[J]. Cell Tissue Res,2017,367(3):427-444.
[4] Shukla VV, Ambalavanan N. Recent advances in bronchopulmonary dysplasia[J]. Indian J Pediatr,2021,88(7):690-695.
[5] Stoll BJ, Hansen NI, Bell EF, et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993—2012[J]. JAMA,2015,314(10):1039-1051.
[6] 江苏省新生儿重症监护病房母乳质量改进临床研究协作组. 多中心回顾性分析极低及超低出生体重儿支气管肺发育不良的临床特点及高危因素 [J].中华儿科杂志,2019, 57(1):33-39.
Jiangsu Multicenter Study Collaborative Group for Breastmilk Feeding in Neonatal Intensive Care Units. Clinical characteristics and risk factors of very low birth weight and extremely low birth weight infants with bronchopulmonary dysplasia:Multicenter retrospective analysis[J]. Chin J Pediatr, 2019, 57(1):33-39.
[7] Homan TD, Nayak RP. Short- and long-term complications of bronchopulmonary dysplasia[J]. Respir Care,2021,66(10):1618-1629.
[8] 张蕊, 郑黎强, 潘国伟. 疾病发病风险预测模型的应用与建立[J].中国卫生统计, 2015, 32(4):724-726.
Zhang R, Zheng LQ, Pan GW. Application and establishment of disease risk prediction model[J]. Chin J Health Statistics, 2015, 32(4):724-726.
[9] Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints:Preferred definitions and conceptual framework[J]. Clin Pharmacol Ther,2001,69(3):89-95.
[10] Philpot PA, Bhandari V. Predicting the likelihood of bronchopulmonary dysplasia in premature neonates[J]. Expert Rev Respir Med,2019,13(9):871-884.
[11] Pezza L, Alonso-Ojembarrena A, Elsayed Y, et al. Meta-analysis of lung ultrasound scores for early prediction of bronchopulmonary dysplasia[J]. Ann Am Thorac Soc,2022,19(4):659-667.
[12] Shim SY, Yun JY, Cho SJ, et al. The prediction of bronchopulmonary dysplasia in very low birth weight infants through clinical indicators within 1 hour of delivery[J]. J Korean Med Sci,2021,36(11):e81.
[13] Alvarez-Fuente M, Moreno L, Lopez-Ortego P, et al. Exploring clinical, echocardiographic and molecular biomarkers to predict bronchopulmonary dysplasia[J]. PLoS One,2019,14(3):e0213210.
[14] Valenzuela-Stutman D, Marshall G, Tapia JL, et al. Bronchopulmonary dysplasia:Risk prediction models for very-low-birth-weight infants[J]. J Perinatol,2019,39(9):1275-1281.
[15] Balaji S, Dong X, Li H, et al. Sex-specific differences in primary neonatal murine lung fibroblasts exposed to hyperoxia in vitro:Implications for bronchopulmonary dysplasia[J]. Physiol Genomics,2018,50(11):940-946.
[16] Cai H, Jiang L, Liu Y, et al. Development and verification of a risk prediction model for bronchopulmonary dysplasia in very low birth weight infants[J]. Transl Pediatr,2021,10(10):2533-2543.
[17] Salimi U, Dummula K, Tucker MH, et al. Postnatal sepsis and bronchopulmonary dysplasia in premature infants:Mechanistic insights into "New BPD"[J]. Am J Respir Cell Mol Biol,2022,66(2):137-145.
[18] Hamrick SEG, Sallmon H, Rose AT, et al. Patent ductus arteriosus of the preterm infant[J]. Pediatrics,2020,146(5):e20201209.
[19] Su BH, Lin HY, Chiu HY, et al. Therapeutic strategy of patent ductus arteriosus in extremely preterm infants[J]. Pediatr Neonatol,2020,61(2):133-141.
[20] Wang J, Dong W. Oxidative stress and bronchopulmonary dysplasia[J]. Gene, 2018,678:177-183.
[21] Perez M, Robbins ME, Revhaug C, et al. Oxygen radical disease in the newborn, revisited:Oxidative stress and disease in the newborn period[J]. Free Radic Biol Med,2019,142:61-72.
[22] Dilli D, Özyazici A, Dursun A, et al. Predictive values of plasma KL-6 in bronchopulmonary dysplasia in preterm infants[J]. Turk J Med Sci,2017,47(2):621-626.
[23] Kohno N. Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis[J]. J Med Invest,1999,46(3-4):151-158.
[24] Yang Y, Li J, Mao J. Early diagnostic value of C-reactive protein as an inflammatory marker for moderate-to-severe bronchopulmonary dysplasia in premature infants with birth weight less than 1500 g[J]. Int Immunopharmacol, 2022,103:108462.
[25] Ambalavanan N, Ross AC, Carlo WA. Retinol-binding protein, transthyretin, and C-reactive protein in extremely low birth weight (ELBW) infants[J]. J Perinatol,2005,25(11):714-719.
[26] Griscom NT, Wheeler WB, Sweezey NB, et al. Bronchopulmonary dysplasia:Radiographic appearance in middle childhood[J]. Radiology,1989,171(3):811-814.
[27] 任艳丽, 孔祥永, 杜志方, 等. 不同程度支气管肺发育不良早产儿的临床及影像学特点[J].中国当代儿科杂志, 2015, 17(5):440-444.
Ren YL, Kong XY, Du ZF,et al. Clinical and imaging features of premature infants with different degrees of bronchopulmonary dysplasia[J]. Chin J Contemp Pediatr, 2015, 17(5):440-444.
[28] Kim HR, Kim JY, Yun B, et al. Interstitial pneumonia pattern on day 7 chest radiograph predicts bronchopulmonary dysplasia in preterm infants[J]. BMC Pediatr,2017,17(1):125.
[29] Semple T, Akhtar MR, Owens CM. Imaging bronchopulmonary dysplasia-A multimodality update[J]. Front Med (Lausanne),2017,29(4):88.
[30] Tonson la Tour A, Spadola L, Sayegh Y, et al. Chest CT in bronchopulmonary dysplasia:Clinical and radiological correlations[J].Pediatr Pulmonol,2013,48(7):693-698.
[31] Shin SM, Kim WS, Cheon JE, et al. Bronchopulmonary dysplasia:New high resolution computed tomography scoring system and correlation between the high resolution computed tomography score and clinical severity[J]. Korean J Radiol,2013,14(2):350-360.
[32] Li R, Zhang J. Diagnostic value of chest CT combined with x-ray for premature infants with bronchopulmonary dysplasia[J]. Medicine (Baltimore),2018,97(9):e9723.
[33] van Mastrigt E, Logie K, Ciet P, et al. Lung CT imaging in patients with bronchopulmonary dysplasia:A systematic review[J]. Pediatr Pulmonol,2016,51(9):975-986.
[34] Brenner D, Elliston C, Hall E, et al. Estimated risks of radiation-induced fatal cancer from pediatric CT[J]. AJR Am J Roentgenol,2001,176(2):289-296.
[35] Walkup LL, Woods JC. Newer imaging techniques for bronchopulmonary dysplasia[J]. Clin Perinatol,2015,42(4):871-887.
[36] Higano NS, Spielberg DR, Fleck RJ, et al. Neonatal pulmonary magnetic resonance imaging of bronchopulmonary dysplasia predicts short-term clinical outcomes[J]. Am J Respir Crit Care Med,2018,198(10):1302-1311.
[37] Mulkern R, Haker S, Mamata H, et al. Lung parenchymal signal intensity in MRI:A technical review with educational aspirations regarding reversible versus irreversible transverse relaxation effects in common pulse sequences[J]. Concepts Magn Reson Part A Bridg Educ Res,2014,43A(2):29-53.
[38] Alonso-Ojembarrena A, Lubián-López SP. Lung ultrasound score as early predictor of bronchopulmonary dysplasia in very low birth weight infants[J]. Pediatr Pulmonol,2019,54(9):1404-1409.
[39] Lalitha R, Bitar E, Hicks M, et al. Pulmonary artery dopplers for early prediction of risk for bronchopulmonary dysplasia in extremely low birth weight babies[J]. J Clin Ultrasound,2022,50(3):385-392.

PDF(550 KB)

Accesses

Citation

Detail

段落导航
相关文章

/